Urinary Incontinence — Causes, Symptoms & Treatment Guide — Symptoms, Causes & Treatment | MyMedicPlus

Urinary incontinence (UI) is the involuntary leakage of urine — a symptom that is objectively demonstrable and causes social or hygienic problems. It is one of the most prevalent yet underreported medical conditions, affecting an estimated 420 million people globally. UI is predominantly a condition affecting women — approximately 30% of women over 40 experience UI — but also affects 5–10% of men (most commonly after prostate surgery). Three main types account for the majority of cases: stress urinary incontinence (SUI) — leakage on coughing, sneezing, exercise, or any activity that raises intra-abdominal pressure; urgency urinary incontinence (UUI) — leakage associated with a sudden, strong, uncontrollable urge to void (overactive bladder); and mixed urinary incontinence (MUI) — features of both SUI and UUI. Less common types include overflow incontinence (chronic urinary retention with continuous dribbling) and functional incontinence (inability to reach the toilet due to physical or cognitive impairment). UI has a profound impact on quality of life — causing social isolation, depression, anxiety, sexual dysfunction, and skin complications — yet remains undertreated due to embarrassment and the misconception that it is an inevitable consequence of ageing.

Stress urinary incontinence (SUI): caused by weakness or damage to the urethral sphincter mechanism or pelvic floor support — insufficient urethral closure pressure when intra-abdominal pressure rises acutely. Causes: vaginal childbirth (especially multiple births, instrumental deliveries, large babies — pudendal nerve and fascia damage); pelvic organ prolapse; post-radical prostatectomy (most common cause of SUI in men — sphincter damage); pelvic radiotherapy; oestrogen deficiency (postmenopausal urethral atrophy reduces closure pressure). Urgency urinary incontinence (UUI) / overactive bladder (OAB): detrusor (bladder muscle) overactivity — uninhibited bladder contractions causing sudden urgency and incontinence. Idiopathic (most common), neurogenic (stroke, Parkinson's disease, multiple sclerosis, spinal cord injury — disrupts cortical inhibition of the micturition reflex), bladder stone or tumour, or infection (UTI — transient UI). Overflow incontinence: causes of urinary retention — bladder outlet obstruction (BPH in men, pelvic organ prolapse in women), neurogenic bladder (diabetic cystopathy — afferent neuropathy from diabetes causes impaired bladder sensation, leading to over-distension and overflow), spinal cord injury, medications (anticholinergics, opioids). Risk factors for UI: female sex (4:1 vs. male), increasing age, obesity (excess abdominal weight increases intra-abdominal pressure on pelvic floor), multiparity, constipation (Valsalva straining damages pelvic floor), smoking (chronic cough), menopause, urinary tract infections, constipating or diuretic medications (caffeine, diuretics, ACE inhibitor-induced cough).

Stress urinary incontinence: involuntary urine leakage on exertion — coughing, sneezing, laughing, lifting, running, jumping; leakage is predictable and related to activity; typically small-volume leakage. Urge urinary incontinence: sudden compelling desire to void that cannot be deferred, followed by involuntary leakage before reaching the toilet; associated with increased urinary frequency (voiding more than 8 times in 24 hours) and nocturia (waking 2 or more times at night to void); often triggered by running water, cold weather, or arriving at front door (latch-key urgency). Mixed urinary incontinence: both stress and urgency components present — typically one dominates. Overflow incontinence: constant dribbling or leakage, sensation of incomplete bladder emptying, weak stream (in men with BPH), recurrent UTIs; absent sense of urgency (neurogenic). Nocturia: waking at night to void — may represent nocturnal polyuria, OAB, or poor sleep. Complications: perineal skin breakdown (IAD — incontinence-associated dermatitis), pressure ulcers, urinary tract infections, falls and fractures (rushing to toilet at night), social isolation, depression, and sexual dysfunction.

Clinical history: type of incontinence (stress vs. urgency), severity (severity pad test — 1-hour pad test in clinic or 24-hour pad test at home), impact on quality of life (ICIQ-UI SF — International Consultation on Incontinence Questionnaire, 3 scored items plus 1 QoL question). Bladder diary (frequency-volume chart): 3–7 day record of fluid intake, voiding times, volumes, and leakage episodes — objective assessment of voiding frequency, functional bladder capacity, and 24-hour urine output. Determines if nocturnal polyuria (>33% of 24-hour urine produced at night) is the cause of nocturia. Urinalysis and urine culture: mandatory to exclude UTI and haematuria (bladder cancer). Post-void residual (PVR) ultrasound: >200 mL suggests impaired bladder emptying — overflow incontinence, neurogenic bladder. Physical examination: cough stress test (Valsalva or cough with moderately full bladder — observed leakage with SUI); pelvic organ prolapse assessment (anterior vaginal wall descent = cystocele — supports urethra; worsens SUI); perineal sensation (neurological examination). Urodynamics: cystometry (filling the bladder with saline while measuring detrusor pressure) — gold standard for OAB diagnosis (demonstrates uninhibited detrusor contractions on filling); videocystourethrography combines imaging with pressure-flow studies. Recommended before surgical treatment or if initial treatment fails. Flexible cystoscopy: for haematuria or suspected bladder pathology. Urethral pressure profilometry and sphincter EMG: for neurogenic or complex cases.

Conservative treatment (first-line for all UI): fluid management — reduce caffeine (bladder irritant — increases urgency and frequency; reducing to 1–2 cups/day alone may reduce OAB symptoms by 25%), reduce evening fluid intake to reduce nocturia, maintain total fluid intake at 1.5–2 L/day (dehydration produces concentrated urine that irritates the bladder). Weight loss: 5–10% weight loss reduces UI episodes by 50–70% in overweight women (PRIDE trial). Pelvic floor muscle training (PFMT — Kegel exercises): first-line treatment for SUI and MUI — strengthens levator ani and urethral sphincter; requires at least 3 months of supervised, correct exercise programme (8–12 maximum contractions, 3 times/day); a specialist physiotherapist or continence nurse guides correct technique (avoid bearing down or contracting gluteal muscles instead of pelvic floor). Supervised PFMT achieves continence in 30–40% of women with SUI and significant improvement in further 40%. Bladder training (for UUI): gradually extending the interval between voiding (using urge suppression techniques — distraction, deep breathing, pelvic floor contraction to inhibit detrusor) to re-establish normal voiding intervals of 3–4 hours; reduces urgency incontinence by 60–80% after 4–8 weeks. Vaginal oestrogen (postmenopausal women): topical oestrogen (Vagifem pessary, Ovestin cream) restores urethral mucosa thickness and vascularity — reduces frequency, urgency, and SUI in postmenopausal women; systemic HRT does NOT improve UI and may worsen it. Pharmacological treatment for OAB/UUI: antimuscarinics (oxybutynin 2.5–5 mg TDS or modified-release, solifenacin 5–10 mg OD, tolterodine 2 mg BD, fesoterodine 4–8 mg OD, trospium chloride 20 mg BD) — block M2/M3 muscarinic receptors in detrusor, reducing uninhibited contractions. Common side effects: dry mouth (most common), constipation, blurred vision, cognitive impairment in elderly (avoid oxybutynin in elderly — crosses blood-brain barrier; solifenacin or trospium preferred). Beta-3 adrenoceptor agonist: mirabegron 25–50 mg OD — relaxes detrusor through beta-3 stimulation; no anticholinergic side effects; safe in elderly; may increase blood pressure. Combination mirabegron + solifenacin (BESIDE trial — superior to either alone). Surgical treatment for SUI: midurethral sling (tension-free vaginal tape — TVT; transobturator tape — TOT): small polypropylene mesh tape placed under the mid-urethra through a minimally invasive procedure; cure rates 80–90% at 5 years — gold standard for SUI surgery. Bulking agents (urethral injection — collagen, hyaluronic acid, polyacrylamide hydrogel): less durable than sling (cure rates 50% at 1 year), suitable for those unfit for sling. Burch colposuspension (laparoscopic or open — stitching urethra to Coopers ligament): effective but more invasive — less commonly used. Botulinum toxin A (100 U intradetrusor injection — cystoscopy-guided): for refractory OAB after failed antimuscarinic/mirabegron therapy — reduces urgency and UUI by 50–75% for 6–9 months, requires repeat injection. Sacral neuromodulation (InterStim): implanted sacral nerve stimulator for refractory OAB and non-obstructive urinary retention — highly effective for appropriately selected patients. Tibial nerve stimulation (percutaneous — weekly 30-minute sessions, 12 weeks; or implanted PTNS): non-invasive sacral neuromodulation alternative for OAB.

Urinary incontinence causes a broad range of physical, psychological, and social complications that disproportionately affect older adults, women, and those with limited mobility. Skin complications — perineal dermatitis, maceration, pressure ulcer formation, and secondary fungal (Candida) or bacterial skin infections — result from prolonged skin moisture contact with urine. Falls and fractures: nocturia (nighttime urination) significantly increases the risk of falls during hurried trips to the toilet at night, particularly in elderly patients on sedative medications; urge incontinence with rushing also contributes. Urinary tract infections occur more frequently in incontinent patients, particularly those using incontinence pads or catheters for management. Psychological complications are profound: depression, anxiety, social isolation, and restricted participation in social, employment, and leisure activities significantly impair quality of life and are frequently under-recognised and undertreated. Sexual dysfunction — avoiding intercourse due to fear of leakage — affects intimate relationships. Caregiver burden and nursing home admission are accelerated by severe incontinence in dependent elderly patients. Quality-of-life impairment from incontinence is comparable to major chronic medical conditions, yet many patients do not seek help due to embarrassment or misconception that incontinence is a normal consequence of ageing that cannot be effectively treated.

Pelvic floor muscle training during and after pregnancy significantly reduces UI risk — all women should be offered supervised PFMT antenatally and postnatally. Maintain healthy body weight throughout life — obesity is one of the strongest modifiable risk factors for UI. Treat constipation promptly — chronic straining damages the pelvic floor. Stop smoking — chronic cough from smoking directly damages pelvic floor support. Reduce caffeine intake (coffee, tea, cola, energy drinks) — caffeinated beverages increase detrusor irritability. Exercise regularly (moderate-intensity) — physical activity does not increase UI risk when pelvic floor is well-conditioned. Toilet habits: void every 3–4 hours on a need-to-go basis (not 'just in case' frequent voiding that reduces functional bladder capacity). Topical vaginal oestrogen in postmenopausal women maintains urethral and pelvic tissue health and prevents UI worsening. Annual screening for UI by GPs and practice nurses in all women over 40 — simple 3-question validated screening tools (ICIQ-UI SF) identify those who benefit from assessment. UI is not an inevitable consequence of ageing — effective treatments exist and most patients achieve significant improvement.

See a doctor if urinary leakage is affecting your quality of life, causing you to change activities or pad use, or causing social withdrawal — UI is treatable and you do not need to tolerate it. Seek urgent medical review for: sudden onset of urinary incontinence with back pain, leg weakness, or saddle anaesthesia (perineal numbness) — possible cauda equina syndrome requiring emergency MRI and surgery; blood in the urine with incontinence (haematuria — exclude bladder cancer); new incontinence in a person with Parkinson's disease, MS, or recent stroke (neurogenic UI requiring specialist assessment). See a continence specialist nurse or physiotherapist for pelvic floor assessment before attempting self-directed exercises — many people perform Kegel exercises incorrectly and bear down instead of lifting. Do not accept urinary incontinence as normal ageing — NICE guidelines state that all women with urinary incontinence should be offered an active assessment and treatment plan.